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Abstract
At present, secretin and its receptor have only been identified in mammals, and the origin of this ligand-receptor pair in
early vertebrates is unclear. In addition, the elusive similarities of secretin and orexin in terms of both structures and
functions suggest a common ancestral origin early in the vertebrate lineage. In this article, with the cloning and functional
characterization of secretin receptors from lungfish and X. laevis as well as frog (X. laevis and Rana rugulosa) secretins, we
provide evidence that the secretin ligand-receptor pair has already diverged and become highly specific by the emergence
of tetrapods. The secretin receptor-like sequence cloned from lungfish indicates that the secretin receptor was descended
from a VPAC-like receptor prior the advent of sarcopterygians. To clarify the controversial relationship of secretin and orexin,
orexin type-2 receptor was cloned from X. laevis. We demonstrated that, in frog, secretin and orexin could activate their
mutual receptors, indicating their coordinated complementary role in mediating physiological processes in non-mammalian
vertebrates. However, among the peptides in the secretin/glucagon superfamily, secretin was found to be the only peptide
that could activate the orexin receptor. We therefore hypothesize that secretin and orexin are of different ancestral origins
early in the vertebrate lineage.
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Introduction
Based on structural similarity, secretin (SCT) is classified to the
secretin/glucagon superfamily that also includes vasoactive
intestinal peptide (VIP), pituitary adenylate cyclase-activating
polypeptide (PACAP), PACAP-related peptide (PRP), glucagon,
peptide-histidine-isoleucine (PHI), glucagon-like peptides (GLP-1
and GLP-2), gastric inhibitory polypeptide (GIP), and growth
hormone-releasing hormone (GHRH) [1]. It has been suggested
that several gene and exon duplication events followed by
subsequent modifications of an ancestral gene have given rise to
these structurally similar peptides [2,3]. Secretin was first
discovered as a gastrointestinal hormone with its function in
stimulating pancreatic flow [4]. Recently, various roles of secretin
in the central and peripheral nervous system as well as in other
organs including pituitary, kidney, intestine and heart [5–9] have
further been proposed.
Secretin carries out its hormonal actions through the secretin
receptor (SCTR), which is a member of Class II B1 guanine
nucleotide binding protein (G protein)-coupled receptors (GPCR)
[6]. This class of GPCR utilizes intracellular second messengers
including cyclic AMP and calcium ions in signaling pathways (For
details, see review [9]). The first secretin receptor was isolated
from a rat NG108-15 cell line based on its high affinity for
secretin in transfected COS cells [5]. Subsequently, secretin
receptors were cloned from several mammalian species, including
human [10–12], mouse [13], rat [14], bovine [15] and rabbit
[16].
Orexins A and B [17] or hypocretins 1 and 2 [18] are peptides
isolated from the rat hypothalamus in 1998 by two independent
research groups. Both peptides are derived from the same
precursor protein and are produced by differential proteolytic
cleavage. Because the C-terminal portions of both orexin peptides
resemble the N-terminal of secretin, orexins were proposed to
have originated from secretin or the related peptides in the
secretin/glucagon superfamily [18,19]. This hypothesis was then
examined by studying the bindings of these peptides with their
receptors in mammals and conflicting results were reported.
Porcine SCT was found to displace the binding of [125I] orexin A
in the rat anterior hypothalamus and orexin receptor-transfected
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cells [20]. On the contrary, another research group showed that
SCT was unable to displace [125I] orexin A or induce calcium
elevation in human orexin type-2 receptor-transfected CHO cells
[21]. There were also reports indicating that SCT exhibited
neither agonistic nor antagonistic effects on the human orexin
receptors [22]. To date, orexins have been identified in several
jawed vertebrates, including teleosts (pufferfish and zebrafish) [23],
frog [24], chicken [25] and mammals [18]. Two orexin receptors
encoded by separate genes were found in mammals [17], but in
zebrafish [23] and chicken [26], only type-2 receptors were
isolated. Functionally, orexins are neuropeptides that modulate
energy homeostasis, feeding behavior [27–29], gastrointestinal
secretion [30–32], sleep-wake cycle [33], and drinking behavior
[34]; and it is interesting to note that some of the effects of orexin
overlap with those of secretin [35].
To our knowledge, secretin and secretin receptors have only
been functionally identified in mammals while a secretin-like
peptide sequence has been isolated in chicken [36–38]. To
understand the evolutionary history of secretin and secretin
receptor, we have chosen the African lungfish Protopterus dolloi and
two frog species (Xenopus laevis and Rana rugulosa) for the isolation
of SCT and SCTR homologues as they are extant species in the
Sarcopterygii lineage [39]. Lungfish and the fish ancestors of the
tetrapod lineage are believed to be originated within a short time
window of about 20 million years, back in the early Devonian
(about 380 to 400 million years ago) [40]. Hence, lungfish holds
an important evolutionary position in the vertebrate lineage
extending from the Paleozoic fishes to the tetrapods [38]. Frog
species diversified and radiated in the amphibian lineage,
marking the critical point of Devonian origin of tetrapods from
the transition of aquatic to terrestrial habitats [41,42]. In the
present study, we have cloned and functionally characterized
putative SCTRs from lungfish and frogs, showing for the first
time that a SCTR-like sequence was already present in the lobe-
finned fish dating back to the early Devonian. Functional studies
evidently showed that these putative SCTRs were coupled to
downstream signaling mechanisms involving intracellular cAMP
and calcium ions.
Because of the elusive structural and functional similarities
observed in secretin and orexin peptides in mammals, together
with the conflicting reports on the cross-reactivity of secretin and
orexin with their mutual receptors, we sought to test the ligand-
receptor activation of secretin and orexin in X. laevis that now
remains confined to mammalian studies. We hypothesized that
secretin and orexin receptors could have been functional
complementary partners in mediating physiological processes
before the origin of mammals; and subsequent to the early
divergence of mammals, they became highly specific to their
respective ligands. Our expectation under this hypothesis is that
secretin and orexin could activate their mutual receptors in frog
species, but not in mammalians. Therefore, in addition to
secretin and secretin receptor, the orexin type-2 receptor was
also cloned from X. laevis to clarify the ancestral relationship of
secretin and orexin. We showed that Xenopus orexin A (xOA)
could stimulate calcium transients in both lungfish and X. laevis
SCTRs; while Xenopus secretin (xSCT) could also evoke calcium
elevations in Xenopus orexin type-2 receptor (xOX2R). Substan-
tiated by these reciprocal ligand-receptor activations in non-
mammalian vertebrates, we provide evidence that, secretin and
orexin, could be modulating physiological processes in coordi-
nation before the divergence of mammals; but we found that
such interaction was due to their moderate structural identities
instead of a common ancestral origin early in the vertebrate
lineage.
Results
Identification and Analysis of Putative Secretin Receptors
in P. dolloi and X. laevis
By searching the X. tropicalis genome, DNA sequences that
shared high levels of sequence identity with mammalian SCTRs
were identified. Primers were designed accordingly to amplify the
putative SCTR in X. laevis, and a full-length cDNA of 1841 bp
(GenBank accession no. HQ236552) with an open reading frame
of 1350 bp encoding a 450-amino acid protein was obtained (Fig.
S1). To amplify the SCTR in P. dolloi, degenerative primers were
designed. The full-length putative P. dolloi SCTR cDNA was
1509 bp (GenBank accession no. HQ236551) with an open
reading frame of 1389 bp encoding a 463-amino acid protein
(Fig. S2). Using the CBS Prediction Servers (http://www.cbs.dtu.
dk/services/), putative lfSCTR and xSCTR were shown to
structurally resemble other class II B1 GPCRs with an N-terminal
signal peptide of 28 and 24 amino acids, respectively, a ligand
binding domain and seven transmembrane domains. Phylogenetic
analyses of putative lfSCTR and xSCTR were performed using
the Maximum Likelihood method with the Jones-Taylor-Thorn-
ton (JTT) model (Fig. 1A). PAC1, VPAC1 and VPAC2 receptors
were included for their closer phylogenetic relationships with
SCTRs [8], while PTHR was used as an outgroup. The tree
grouped the putative lfSCTR and xSCTR to the clade of SCTRs,
supporting their identities as the orthologs of mammalian SCTRs.
Moreover, phylogenies inferred from the SCTR sub-branch are
consistent with the divergence of vertebrate groups. The overall
tree containing the analyzed receptors is in agreement with the
published observations [43]. When compared to human, rat,
mouse, rabbit, and bovine SCTR, lfSCTR and xSCTR shared
58.8–71.0% sequence identity in the ligand-binding domain (Fig.
S3A), and 62.6–69.0% identity for the entire receptor (Fig. S3B).
Structurally, the six cysteine residues involved in the formation of
three disulphide linkages within the ectodomain [44,45] and the
third endoloop (IC3), as well as the RLAR/K motif for Gs
coupling [46] were conserved in lfSCTR and xSCTR (Fig S4).
Interestingly, the IIRIL motif that was believed to be unique to
VPAC1 receptors [47] was found in all secretin receptors.
Moreover, the PDI/V motif present in all VIP receptors [47]
was also found in lfSCTR. In chromosomal synteny analysis
(Fig. 1B), SCTR genes were located in close proximity to the
Tmem37 genes in all the analyzed species. This information
therefore supports that the SCTR gene in X. tropicalis is
homologous to the mammalian SCTR genes.
Molecular Cloning of X. laevis and R. rugulosa Secretin
Precursors
The predicted amino acid sequences of Xenopus and Rana SCT
precursors are shown in Fig. S5, S6 (X. laevis secretin (xSCT)
cDNA GenBank accession no. HQ236553 and Rana secretin
(Rana SCT) cDNA GenBank accession no. HQ236554). Both
precursors encode a 28-amino acid secretin peptide predicted by
the conserved GKR motif as cleavage site. Alignment of frog SCT
with other SCTs showed identical residues at positions 1, 3, 4, 7, 8,
9 11 and 17 (Fig. S7A) and 57.1–96.4% sequence identity (Fig.
S7B). Rana SCT and the predicted X. tropicalis SCT are identical
while they differ from xSCT by 1 residue at position 5. The
phylogenetic relationship of SCT precursors was analyzed with the
precursors of the other secretin/glucagon superfamily peptides
(Fig. 2A). Precursors instead of mature peptides were used in the
analysis because the mature peptides are too short for phylogenetic
studies (less than 50 amino acid residues). In the tree, frog, avian
and mammalian SCT precursors formed three sub-branches in the
Secretin Receptor Origin and Orexin
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same clade, which are consistent with the established phylogenies
of these species. In an attempt to analyze the SCT genes in
vertebrates, their genomic locations in human, mouse, bird,
chicken and X. tropicalis were mapped (Fig. 2B). The overall
genomic arrangement of the SCT loci was syntenic, as shown by
genes such as DRD4, DEAF1, and ASCL2, although the gene
environment of SCT in X. tropicalis was less conserved compar-
atively. This could be attributed to the incomplete assembling of
Figure 1. Analyses of secretin receptor phylogeny and in silico genomic locations. (A) Receptor phylogeny: phylogenetic analysis of
vertebrate receptors in Class II B1 GPCR. The tree was generated by Maximum Likelihood (ML) and plotted by MEGA 5.0. Receptors cloned in the
present study are marked by an asterisk. Diverged from the ancestral VPAC-like receptor (denoted by a black dot), the P. dolloi SCTR retained the VIP/
PACAP functions (branch in dotted line); whereas the X. laevis and mammalian SCTRs acquired the specificity towards secretin (branch in thick solid
black line). PTHR, parathyroid hormone receptor; SCTR, secretin receptor; PAC1, pituitary adenylate cyclase-activating polypeptide (PACAP) receptor
type I; VPAC1, vasoactive intestinal peptide (VIP)-PACAP receptor I; VPAC2, VIP-PACAP receptor II. (B) Chromosomal locations of secretin receptor in
various vertebrate species. Genes adjacent to secretin receptor in different vertebrate genomes are shown. Homologous genes present in different
species are linked to show their similarities in chromosomal location.
doi:10.1371/journal.pone.0019384.g001
Secretin Receptor Origin and Orexin
PLoS ONE | www.plosone.org 3 April 2011 | Volume 6 | Issue 4 | e19384
scaffolds in the X. tropicalis genome, or it is reflecting the
occurrence of some major evolutionary events that took place in
amphibian divergence. Despite our efforts, we could neither
identify a secretin-like sequence in P. dolloi by molecular cloning,
nor any secretin-like sequence in various fish genome databases by
informatics.
Comparison of Functional Properties of lfSCTR and xSCTR
To functionally characterize the putative lfSCTR and xSCTR,
CHO cells transiently transfected with these receptors were
stimulated by SCT or related peptides, and intracellular cAMP
production ([cAMP]i) as well as intracellular Ca
2+ mobilization
([Ca2+]i) were monitored. Among all the peptides tested, hSCT,
Figure 2. Analyses of secretin phylogeny and in silico genomic locations. (A) Ligand Phylogeny: phylogenetic analysis of the secretin/
glucagon hormone precursor superfamily. The tree was generated by Maximum Likelihood (ML) and plotted by MEGA 5.0. Sequences determined in
the present study are marked by an asterisk. SCT, secretin precursor; preproGHRH, prepro-growth hormone-releasing hormone; PHI-VIP, peptide
histidine isoleucine-vasoactive intestinal peptide precursor; PRP-PACAP, pituitary adenylate cyclase-activating polypeptide (PACAP)-related peptide-
PACAP precursor. (B) Chromosomal locations of secretin genes in various vertebrate species. Neighboring genes of secretin in different vertebrate
genomes are shown. Homologous genes in proximity of secretin are linked by straight lines to demonstrate the syntenic gene environment of
secretin in the analyzed vertebrate species.
doi:10.1371/journal.pone.0019384.g002
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xSCT, hVIP, and hPACAP27 (100 nM) were able to significantly
stimulate lfSCTR (Fig. 3A). The xSCTR was found highly specific
to xSCT in both functional assays (Fig. 3B, 3D and 3F) ([cAMP]i
EC50 = 0.24 mM and [Ca
2+]i EC50 = 2.52 nM). Graded concen-
trations of these peptides stimulated both SCTRs dose-depen-
dently (Fig. 3C and D). As shown by the EC50 values, the order of
specificity in activating lfSCTR was hVIP (0.16 mM).hPACAP27
(0.41 mM).hSCT (0.79 mM).xSCT (1.82 mM). Despite that the
peptides were weakly potent as shown by their sub-micromolar
EC50 values, their abilities to stimulate in a concentration-
dependent manner cAMP response showed that they were fully
efficacious agonists of this receptors. Of interest is the agonistic
effect of hSCT on lfSCTR stimulation. While hSCT was less
potent than hVIP and hPACAP27 in activating lfSCTR, at micro-
molar concentrations (1025 and 1026 M), hSCT was 3.6 and 5.0
fold more efficacious than hVIP and hPACAP27 respectively in
triggering [cAMP]i in lfSCTR-CHO cells. In addition to cAMP
stimulation, exposure of lfSCTR-transfected CHO cells preloaded
with the Ca2+-sensitive dye Fluo-3 to hSCT, xSCT, hVIP, and
hACAP27 evoked transient [Ca2+]i increase in a dose-dependent
manner (Fig. 3E). As shown by their EC50 values, the order of
specificity was hVIP (10.3 nM).hSCT (14.7 nM).hPACAP27
(25.6 nM).xSCT (273.1 nM), which is in agreement with the
cAMP assay. By confocal imaging, real-time traces from single
cells were recorded (Fig. S8). Ionomycin, an ionophore, was added
at the end of each trial to ensure that [Ca2+]i elevation was not
caused by cell lysis.
Tissue Expression of X. laevis secretin, P. dolloi and X.
laevis Secretin Receptors
To examine their potential sites of action, the expression profiles
of xSCT, xSCTR and lfSCTR transcripts were studied by the
quantitative PCR technique (Fig. 4). All the transcripts were found
widely expressed in lungfish and X. laevis, and the X. laevis intestine
exhibited the highest co-expression of SCT and SCTR. This co-
expression extended to the gastrointestinal tract (stomach and
pancreas), lung and kidney. Expression of the xSCT transcript was
also detected in the brain, while its receptor was relatively weakly
expressed in this tissue. Unlike the most abundant expression of
xSCTR in the digestive system, lfSCTR had the highest transcript
level in the brain, and less in gall bladder, female gonad and
pancreas.
In Vitro Activation by xSCT on R. rugulosa Pancreatic
Ductal Cells
The function of mammalian secretin in stimulating pancreatic
secretion is well-established. In our study, we have therefore tested
the function of xSCT by monitoring in vitro cAMP stimulation
using primary pancreatic ductal cell culture prepared from R.
rugulosa (Fig. 5). As an indicator of cell viability upon overnight
culture, sealing of both ends of the pancreatic ducts were observed
under microscope. xSCT was found to dose-dependently stimu-
late cAMP production; thus, affirming its effect on activating
pancreatic secretion in frogs. Forskolin was used in each
independent trial as a positive control and was able to induce a
20-fold increase in cAMP level when compared with the basal.
Reciprocal Activation of Secretin and Orexin Receptors
by their Mutual Endogenous Ligands
Since SCT was found only in frogs but not in lungfish, we are
thus limited to testing the reciprocal activation of SCT and orexin
with their receptors in frogs. In this study, we cloned the first
amphibian orexin type-2 receptor from X. laevis (xOX2R, cDNA
GenBank accession no. HQ242647) (Fig. S9). Type-2 orexin
receptor was cloned because it is the only orexin receptor present
and has previously been characterized in non-mammalian verte-
brates. xOX2R shares a high level of sequence identity (80%) and
structural similarity with its mammalian orthologs. lfSCTR,
xSCTR and xOX2R were transiently expressed and exposed to
graded concentrations of Xenopus orexins and secretin followed by
measurements of intracellular cAMP accumulation and calcium
mobilization. Interestingly, xOA, but not xOB, could increase
dose-dependently calcium level in both lfSCTR- (EC50 = 1.2 nM)
and xSCTR- (EC50 = 8.6 nM) transfected cells (Fig. 3E and F
respectively). In xOX2R-expressing cells, orexins (xOA and xOB)
and xSCT could trigger dose-dependent [Ca2+]i elevations, but
not intracellular cAMP accumulation, with EC50 values at
2.0 nM, 215 nM, and 146 nM, respectively (Fig. 6 and S10).
Other peptides of the secretin/glucagon superfamily failed to elicit
any responses in both cAMP and calcium assays (data not shown).
These data suggest that calcium mobilization instead of cAMP is
used as the main signaling pathway for orexin receptors from
amphibians to mammals. Human orexin A and B were also able to
induce calcium elevations in xOX2R-CHO cells, but not in
SCTR-expressing cells (data not shown).
Discussion
Structural and Functional Evolution of SCTR in
Vertebrates
To examine the origin of secretin receptor, previously known
only from mammals, we tried to clone orthologs from more
distantly related species – frog (X. laevis) and lungfish (P. dolloi). We
identified orthologs (xSCTR and lfSCTR), indicating that this
receptor originated much earlier than previously thought. Its
cognate ligand, secretin, was only found in X. laevis but not in
lungfish. Despite repeated trials on varying conditions and
different designs of degenerate primers, we were not able to
amplify a secretin-like sequence in lungfish. As the same PCR-
based approach was adopted for the molecular cloning of secretin
in frog and lungfish, we evaluated the failure in lungfish was
probably attributed to the absence of secretin. Because the
genomes of lungfish and other lobe-finned fish are not available,
we tried to search for secretin-like sequences in other fish genomes
(fugu, medaka, zebrafish, tetraodon, and stickleback). Again,
secretin-like sequences were not found (data not shown).
Substantiated by these evidences, we proposed that secretin does
not exist in fish.
As shown by functional assays, both xSCTR and lfSCTR were
coupled to cAMP and calcium signaling pathways albeit
differential ligand affinities. Our data indicated that xSCTR is
highly selective for frog SCT over other secretin-related peptides
tested. On the other hand, it is interesting to note that hVIP and
hPACAP were consistently more specific than hSCT and xSCT in
stimulating lfSCTR in both cAMP and calcium pathways. Since
PACAP and VIP are highly conserved peptides in vertebrates, and
since we are unable to find secretin sequences in fish, we therefore
hypothesize here that although the lungfish SCTR is structurally
more similar to SCTRs in vertebrates, it functions as a VIP/
PACAP receptor in this fish model.
Based on these findings and topology of the phylogenetic tree,
we postulate that SCTR was descended from a VPAC-like
receptor early in the vertebrate lineage (Figure 1A). Suggested by
its newly discovered role in water homeostasis in mammals
[48,49], it is possible that the occurrence of SCTR in the
Sarcopterygii lineage prior the emergence of tetrapods was used
for the change from aquatic to terrestrial habitat. Due to its origin,
Secretin Receptor Origin and Orexin
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Figure 3. Functional characterization of lfSCTR and xSCTR. Intracellular cAMP accumulation ([cAMP]i) in response to 100 nM of the secretin
and related peptides on CHO-K1 cells transfected with (A) lfSCTR and (B) xSCTR (*** indicates P,0.001). Effects of graded concentrations of peptides
on (C) lfSCTR- and (D) xSCTR-expressing cells. Peptide species: h, human; x, X. laevis, zf, zebrafish Danio rerio; gf, goldfish Carassius auratus. Values
represent mean 6 SEM (n= 4). Effects of secretin and related peptides on intracellular calcium mobilization ([Ca2+]i) in recombinant CHO cells
expressing (E) lfSCTR and (F) xSCTR. Transiently transfected cells expressing the receptors were stimulated with graded concentrations of peptides.
Data were expressed in DRFU value (maximum changes in the fluorescence signals from baseline) and converted to percentage of the maximum of
xSCT-induced [Ca2+]i elevation. Results are expressed as mean 6 SEM from at least 10 independent experiments, cell number = 20 to 50.
doi:10.1371/journal.pone.0019384.g003
Secretin Receptor Origin and Orexin
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the lfSCTR is still able to interact with and be activated by VIP
and PACAP, possibly by retaining the VIP/PACAP recognition
motifs (e.g. IIRIL and PDI/V). The SCTR then co-evolved with
SCT leading to the divergence of functional SCT/SCTR axis
paralleled with the emergence of amphibians. Descended from
lobe-finned fish, the SCTR-like sequence gradually increased its
Figure 4. Tissue expression profile of xSCT, lfSCTR and xSCTR. Using real-time RT-PCR, the tissue distribution patterns of lfSCTR, xSCT and
xSCTR were investigated on P. dolloi and X. laevis. The expression level of each gene was calculated from respective standard curve. Data are
expressed as mean 6 SEM (n= 4).
doi:10.1371/journal.pone.0019384.g004
Figure 5. Effects of xSCT on cAMP production in primary
culture of R. rugulosa pancreatic ductal cells. Graded concentra-
tions of xSCT dose-dependently stimulated the [cAMP]i in cultured
pancreatic ductal cells. Forskolin was used in each experiment as a
positive control to show the viability of the pancreatic ductal cells. Data
are expressed as mean 6 SEM (n= 4, *** indicates P,0.001).
doi:10.1371/journal.pone.0019384.g005
Figure 6. Effects of X. laevis secretin and orexin peptides on
[Ca2+]i in xOX2R-CHO cells. Data are expressed as DRFU value
(maximum changes in the fluorescence signals from baseline) and
converted to percentage of maximum xSCT-induced [Ca2+]i increase.
Results are expressed as mean 6 SEM from 10 independent
experiments, cell number= 20 to 50.
doi:10.1371/journal.pone.0019384.g006
Secretin Receptor Origin and Orexin
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specificity and sensitivity towards the newly appeared SCT, until it
became fully functional as a specific receptor for SCT; and as a
result, functions of VIP/PACAP and SCT were independently
regulated in tetrapods.
Although we did not identify a SCT-like sequence in lungfish,
we cannot exclude the possibility of the presence of a SCT-like
peptide in lungfish or other lobe-finned fish species (e.g.
coelacanth). If a SCT-like peptide does exist before the divergence
of amphibians, it suggests that the fish secretin could have
contributed to the modeling of SCTR’s ligand specificity in
direction to establish a functional SCT-SCTR axis in amphibians.
Cross-Interactions of SCT and Orexin with their Receptors
in Frog
The question of whether secretin and orexin as well as their
receptors shared the same origin early in the vertebrate lineage is
elusive and was a controversial issue in the past. In the present
study, with the cloning of orexin type-2 receptor from X. laevis, we
demonstrated that, in frog, orexin and secretin could reciprocally
activate their receptors. Of all the secretin/glucagon superfamily
peptides, the ability of stimulating orexin receptor is, however,
limited to secretin. Hence, it is unlikely that orexin and secretin are
sharing a common ancestral origin since the superfamily peptides
are well documented for their cross reactivity towards each other’s
receptors [50–52]. Structurally, frog secretin and orexin share
moderate sequence homology (43%) when the N-terminus of SCT
(HAAGILT) is compared to the C-terminus of OA (HVDGRFT).
As the N-terminus of SCT is crucial for receptor binding, the
observed structural similarity shared by these peptides, likely due
to convergent evolution, may explain their cross reactivity with
respective receptors.
The interesting reciprocal ligand-receptor activation exhibited
hereby suggests that secretin and orexins were complementary
partners in mediating similar and/or overlapping physiological
processes via stimulating SCTR and OX2R in non-mammalian
vertebrates of the Sarcopterygii lineage. Taking together the ability
of orexin in activating lfSCTR, we postulate a major alteration of
ligand-receptor interaction of secretin and orexin by the advent of
mammals. Before the divergence of mammals, SCT and orexin A
were in coordination in activating SCTR and OX2R; while orexin
B is specific to activating OX2R to mediate functions distinct from
those controlled by SCT and orexin A. By the divergence of
mammals, orexin type-1 receptor (OX1R) emerged to facilitate
the precise control over the biological functions mediated by
orexin receptors. OX2R in mammals retained its ligand specificity
for orexin A and B descended along the vertebrate lineage; while
OX1R is specifically activated by orexin A. The functional
diversifications of orexin receptors and SCTRs in mammals were
fine-tuned to be activated by their own endogenous peptides,
resulting in the loss of the reciprocal activation observed in non-
mammalian vertebrates.
Though secretin and orexin evolved independently, their
functions converged at some point in the vertebrate lineage. This
convergent evolutionary pattern is, however, not limited to secretin
and orexin. For instance, the intraflagellar transport (IFT) genes
and Regulatory Factor X transcription factors (RFX TFs) have
recently been reported to have evolved independently in pre-
metazoans, and their evolution converged to establish a transcrip-
tional regulatory relationship in metazoans [53]. It was suggested
that the convergent molecular evolution of IFT genes and RFX
TFs could have provided a pivotal driving force in the evolution
and emergence of metazoans [53]. In the case of secretin and
orexin, their convergence was likely the result of selection by similar
adaptive pressures [54,55]. Their complementary mediation on
crucial biological functions could have driven the establishment of
enhanced and networked control for the adaptation of amphibians
in both terrestrial and aquatic habitats. Analogy of secretin and
orexin could have been established by the neutral drift of molecular
adaptation, in which the neutral emergence of non-specific binding
was one of the possible mechanisms.
Integration of our current findings, we conclude that secretin
receptors are not exclusively expressed and functional in
mammals, thus are not encoded from gene(s) that were duplicated
or modified along with the speciation of mammals. Their tissue-
specific expression and abilities in triggering classical GPCR
signaling pathways affirmed that they were already physiologically
functional prior mammalian divergence, and are most likely
descended from a VPAC-like receptor prior the sarcopterygian-
actinopterygian split that occurred after the second round of whole
genome duplication. We also showed that, despite the reciprocal
activation of secretin and orexin receptor by their mutual
endogenous ligands in non-mammalian vertebrates, secretin and
orexin are of different ancestral origins early in the vertebrate
lineage. We speculate that the analogy observed in secretin and
orexin was a result of convergent evolution, in which their cross-
reactivity could be established by the neutral emergence of non-
specific binding.
Materials and Methods
Ethics Statement
All animal treatments were in accordance with the guidelines
established by the Committee on the Use of Live Animals in
Teaching and Research (CULATR, Approval ID 1496-07) of the
University of Hong Kong with the Cap. 340 animal license issued
by the Department of Health of the Hong Kong Government
under the Animals Ordinance.
Animals and Peptides
Lungfish P. dolloi and frog R. rugulosa were purchased from a
local commercial supplier, and X. laevis was bought from Xenopus
I (Xenopus I, Inc., CA). Glucagon, glucagon-like peptides, GIP,
GHRH, PRP, PACAP peptides were ordered from the Proteomics
Resource Center of the Rockefeller University (http://proteomics.
rockefeller.edu/). Xenopus orexin A and B were ordered from
Shanghai HanHong Chemical (Shanghai HanHong Chemical
Co., Ltd., Shanghai, China). VIP and PHI peptides were
synthesized by Bachem California (Bachem California, Inc.,
CA). Human SCT was bought from AnaSpec (AnaSpec, Inc.,
CA), and xSCT was synthesized by one of us (Alain Fournier). All
synthetic peptides were of .95.0% purity.
Total RNA Extraction and First-strand cDNA Synthesis
Animals were sacrificed by cervical decapitation. Total RNA
was isolated from freshly excised tissues by TriPure reagent
according to the manufacturer’s instructions (Invitrogen, Carlsbad,
CA). First-strand cDNA from 5 mg total RNA was synthesized
according to the protocol of SuperScript III Reverse Transcriptase
(Invitrogen) using the Adaptor Primer (AP) (Invitrogen).
Molecular Cloning of Frog Secretins, Secretin Receptors
from P. dolloi and X. laevis, and X. laevis Orexin Type-2
Receptor
Primers for the amplification of X. laevis SCT (xSCT), SCTR
(xSCTR), and orexin type-2 receptor (xOX2R) and R. rugulosa SCT
(Rana SCT) were designed based on the partial sequences obtained
from the X. tropicalis genome by a BLAST search. Degenerate
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primers for the amplification of lungfish SCTR (lfSCTR) were
designed according to conserved regions of aligned SCTR
sequences (Primer List, Table S1). Rapid amplification of cDNA
ends (RACE) was performed using the 59 and 39 RACE
amplification kits (Invitrogen) with specific primers designed
according to the partial sequences. Full-length cDNA clones
encompassing the 59 to 39 untranslated regions were produced by
PCRwith specific primers and confirmed by DNA sequencing. Full-
length SCTR cDNAs were subcloned to pcDNA3.1 (+) (Invitrogen)
for functional expression. All sequences newly identified in the
present study have been deposited in the GenBank (Genbank
accession no.: xSCT, HQ236553; xSCTR, HQ236552; xOX2R,
HQ242647; Rana SCT, HQ236554; lfSCTR, HQ236551).
Tissue Distribution of Secretin and Secretin Receptor in P.
dolloi and X. laevis
Quantitative real-time PCR was used to determine the
expression profiles of SCT and SCTR in P. dolloi and X. laevis in
various tissues. First-strand cDNAs were synthesized from total
RNA as previously mentioned (Materials and Methods: Total
RNA Extraction and First-strand cDNA Synthesis). RT-PCR
(n= 4, each in duplicates) was performed using the Power SYBR
Green PCR Master Mix (Applied Biosystems, Foster City, CA)
and the 7300 Real Time PCR System (Applied Biosystems).
Primers used in the real-time PCR are listed in Table S1. The
threshold cycle (Ct) is defined as the fractional cycle number at
which the fluorescence reaches 10-fold standard deviation of the
baseline (from cycle 3 to 10). The specificity of the SYBR PCR
signal was confirmed by both melt curve analysis and agarose gel
electrophoresis. Standard curves were established by 106 serial
dilution of respective plasmid stocks.
Transient Expression of Secretin and Orexin Receptors in
CHO cells
Chinese Hamster Ovary (CHO) cells (ATCC, Manassas, VA)
were cultured in MEM/10% FBS/100 U/ml Penicillin/100 g/ml
Streptomycin on 100 mm tissue culture plates at 37uC and 5%
CO2 until 80% confluence. SCTR or OX2R expression construct
(2 mg) was used to transfect 16105 CHO cells with 6 ml GeneJuice
reagent (Novagen, Darmstadt, Germany). A control cell line was
established by transfecting the cells with the pcDNA 3.1 (+) vector
(Invitrogen). Intracellular cAMP production upon peptide stimu-
lation was measured using the LANCE cAMP assay kit (Perkin-
Elmer, Waltham, MA) in the Victor64 multilabel reader (Perkin-
Elmer) according to the manufacturer’s protocol. Intracellular
cAMP levels ([cAMP]i) were measured and expressed as cAMP
concentration relative to the basal level (stimulation buffer alone
without peptide addition). Negative control experiments were
performed by simultaneous peptide stimulation at 10 mM on the
control cell line in each experimental trial.
For confocal calcium imaging, transiently transfected cells were
plated at a density of 3000 cells/well in 24-well plates (Sigma-
Aldrich, St. Louis, MO). After overnight incubation, cells were
pre-loaded with 5 mM Fluo-3 acetoxymethyl ester (AM) (Sigma)
for 45 min at 37uC in Tyrode solution consisting of (mM): 140
NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 glucose and 10 HEPES at
pH 7.4. Calcium transient of single receptor-transfected CHO cell
was recorded with a confocal imaging system (Olympus Fluoview
System version 4.2 FV300 TIEMPO) mounted on an upright
Olympus microscope (IX71). Peptides at concentrations ranging
from 1025 to 10212 M were added at designated time point and
calcium level was traced in a real-time manner using the Fluoview
software (Olympus). Data were expressed in DRFU value
(maximum changes in the fluorescence signals from baseline)
and converted to percentage of the maximum of xSCT-induced
[Ca2+]i elevation (i.e. xSCT [Ca
2+]i at 10 mM=100%). For both
assays, ionomycin (10 mM) was added at the end of each
experiment to test the vitality of the cells.
In Vitro Activation by xSCT on R. rugulosa Pancreatic
Ductal Cells in Primary Culture
Adult male R. rugulosa was sacrificed by cervical decapitation.
The freshly excised pancreas was removed and washed in Ringer
solution (in mM, 85 NaCl, 4 KCl, 17.5 NaHCO3, 0.8 KH2PO4, 2
glucose, 1.5 CaCl2 and 0.8 MgCl2, pH 7.6). The excised pancreas
was then minced into approximately 1 mm3 pieces and digested at
room temperature for 1 hr in the dissociation medium (Ringer
solution supplemented with 0.2 mg/ml soy beans trypsin inhibitor
(Sigma), 2 mg/ml BSA (Roche), 400 U/ml hyaluronidase (Sigma)
and 50 U/ml collagenase (Sigma)). The tissue suspension was then
washed with Ringer solution and small clusters of dissociated cells
were filtered with the use of a 100-mm cell strainer (BD Falcon,
US). Filtrate containing the undigested tissue, including the
pancreatic ducts, was maintained in culture medium (80%
Leibovitz’s L-15 medium (Invitrogen) supplemented with 10%
FBS and 100 U/ml Penicillin/100 g/ml Streptomycin) in a
humidified incubator at 24uC. Upon overnight culture, both ends
of the pancreatic ducts sealed with the lumens dilated due to
accumulation of the secretion as seen under microscope. The
isolated pancreatic ductal cells were then used for cAMP
stimulation in the presence of xSCT peptides and forskolin.
Phylogenetic Analysis
Amino acid sequences were aligned with Clustal X, and
phylogenetic trees were constructed using MEGA 5.0 software
[56]. The best-fit models of the trees were selected by ProtTest 3.0
[57]. The trees were calculated by Maximum Likelihood method
with the Jones-Taylor-Thornton (JTT) model and combined with
+I: invariable sites, +G: rate heterogeneity among sites, +F:
observed amino acid frequencies. 1000 bootstrap simulations were
used to test the reliability of branching. Numbers on the nodes of
the tree indicated the percentage of bootstrap replicates in which
the labeled branch was reproduced. Sequences used in these
analyses and their accession numbers retrieved from Genbank and
Ensembl are shown in Table S2.
Statistical Analysis
Results are presented as mean 6 SEM, and are averages of the
means of duplicated assays in at least three independent
experiments. GraphPad Prism version 3.0 (GraphPad Software,
Inc., San Diego, CA) was used to plot the sigmoidal curves in the
cAMP and calcium mobilization assays and to perform statistical
analyses using one-way ANOVA followed by Dunnett’s test.
Differences were considered significant when P,0.05.
Supporting Information
Figure S1 Nucleotide (GenBank accession no. HQ236552) and
deduced amino acid sequence of the X. laevis secretin receptor
(xSCTR) cDNA. Nucleotides (lower line) and amino acids (upper
line) are numbered from the initiation methionine. The signal
peptide (24 amino acids) is indicated in bold characters.
Transmembrane domains are underlined with solid lines.
(PPTX)
Figure S2 Nucleotide (GenBank accession no. HQ236551) and
deduced amino acid sequence of the P. dolloi secretin receptor
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(lfSCTR) cDNA. Nucleotides (lower line) and amino acids (upper
line) are numbered from the initiation methionine residue. The
signal peptide (28 amino acids) is indicated in bold characters.
Transmembrane domains are underlined with solid lines.
(PPTX)
Figure S3 Percent amino acid homology of vertebrate secretin
receptor (A) ligand-binding domain and (B) entire sequence.
(PPTX)
Figure S4 Alignment of cloned secretin receptor amino acid
sequences. Putative transmembrane domains are overlined and
labeled. # and * indicate potential sites for N-linked glycosylation
and conserved cysteine residues, respectively. Predicted ligand-
binding domains are indicated in bold characters. Structural
features are boxed with dotted lines. Gaps (represented by - ) were
introduced to maximize sequence homology.
(PPTX)
Figure S5 Nucleotide (GenBank accession no. HQ236553) and
deduced amino acid sequence of the X. laevis secretin (xSCT)
cDNA. The full-length xSCT is 2141 bp in length. Nucleotides
(lower line) and amino acids (upper line) are numbered from the
initiation methionine residue. The signal peptide (20 amino acids)
is indicated in bold characters. The mature peptide (28 amino
acids) is underlined with solid line and the potential cleavage/
amidation site (GKR) is boxed.
(PPTX)
Figure S6 Nucleotide (GenBank accession no. HQ236554) and
deduced amino acid sequence of the R. rugulosa secretin (Rana
SCT) cDNA. The full-length Rana SCT is 763 bp in length.
Nucleotides (lower line) and amino acids (upper line) are
numbered from the initiation methionine residue. The signal
peptide (22 amino acids) is indicated in bold characters. The
mature peptide (28 amino acids) is underlined with solid line and
the potential cleavage/amidation site (GKR) is boxed.
(PPTX)
Figure S7 Sequence analyses of secretin mature peptides. (A)
Alignment of secretin mature peptide sequences. Identical residues
are indicated in bold characters. Accession numbers are: H. sapiens,
AAG31443; R. norvegicus, AAA42128; M. musculus, CAA51982; B.
taurus, P63296; C. familiaris, P09910; O. cuniculus, P32647; S. scrofa,
AAA31121; G. gallus, NP_001020004. (B) Percent amino acid
homology of the aligned secretin mature peptides.
(PPTX)
Figure S8 Representative traces of hPACAP27, hSCT, hVIP,
xOA, and xSCT on intracellular calcium mobilization in lfSCTR,
xSCTR and null pcDNA 3.1-transfected CHO cells. Peak
magnitude of traces is proportional to the order of potency of
the ligands tested. Traces were obtained from at least 10 calcium
assays with respective control shown on the right panel. Ionomycin
(10 mM) was added at the end of each experiment to test the
vitality of the cells.
(PPTX)
Figure S9 Full-length nucleotide (GenBank accession no.
HQ242647) and deduced amino acid sequence of X. laevis orexin
type-2 receptor (xOX2R). Numbers on the left and right indicate
the position of the first nucleotide and the last amino acid of each
line from the start codon, respectively. The ORF sequence is
presented in upper cases whereas the 39 and 59 UTR sequences
are presented in lower cases. The amino acid sequences corre-
sponding to the seven putative transmembrane domains (TM1-7)
are labeled and underlined. The stop codon is marked by an
asterisk sign (*).
(PPTX)
Figure S10 Representative traces of xSCT, xOA, and xOB on
intracellular calcium mobilization in xOX2R- and null pcDNA
3.1-transfected CHO cells. Peak magnitude of traces is propor-
tional to the order of potency of the ligands tested. Traces were
obtained from at least 10 calcium assays with respective control
shown on the right panel. Ionomycin (10 mM) was added at the
end of each experiment to test the vitality of the cells.
(PPTX)
Table S1 List of primers used in PCR and real-time PCR
amplifications.
(PPTX)
Table S2 Accession numbers of amino acid sequences of
secretin/glucagon superfamily hormones and GPCR secretin
family receptors [58,59].
(PPTX)
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